Blue Cross and Blue Shield of North Carolina expands Specialty Pharmacy precertification list (Healthy Blue + Medicare (HMO D-SNP))

July 31, 2023
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Blue Medicare
media-label
label
link
Blue Medicare
icon-position
right
full-width
false
full-width-mobile
false

Please note, this communication applies to Healthy Blue + Medicare℠ (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Effective for dates of service on and after October 1, 2023, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

lh-header-fill
true
lh-sticky-header-column
true
HCPCS or CPT® Codes Medicare Part B Drugs
J9999 Adstiladrin (nadofaragene firadenovec-vncg)
J3490, J3590 Altuviiio (antihemophilic factor (recombinant)
J3490, J3590 Idacio (adalimumab-aacf)
C9399, J3490 Lamzede (velmanase alfa-tycv)
C9399, J3490, J3590, J9999 Lunsumio (mosunetuzumab-axgb)
C9399, J3490, J3590 Rebyota (fecal microbiota, live – jslm)
J2502 Signifor LAR (pasireotide)
C9399, J3490 Syfovre (pegcetacoplan)
J9999 Vivimusta (bendamustine)
For more information, please visit Healthy Blue + Medicare.